{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:06:47Z","timestamp":1790644007362,"version":"4.1.0"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430034"],"award-info":[{"award-number":["81430034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jtauto.2019.100018","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:28:14Z","timestamp":1570559294000},"page":"100018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Polymyositis and dermatomyositis \u2013 challenges in diagnosis and management"],"prefix":"10.1016","volume":"2","author":[{"given":"Shu-Han","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"issue":"9388","key":"10.1016\/j.jtauto.2019.100018_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1759720X11425092","article-title":"Diagnosis and treatment of inflammatory myopathy: issues and management","volume":"4","author":"Castro","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"18","key":"10.1016\/j.jtauto.2019.100018_bib5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5114\/reum.2015.51510","article-title":"Polymyositis and dermatomyositis as a risk of developing cancer","volume":"53","author":"Jakubaszek","year":"2015","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12016-016-8527-x","article-title":"The immune response and the pathogenesis of idiopathic inflammatory myositis: a critical review","volume":"52","author":"Ceribelli","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11926-000-0080-0","article-title":"Familial autoimmunity and the idiopathic inflammatory myopathies","volume":"2","author":"Shamim","year":"2000","journal-title":"Curr. Rheumatol. Rep."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1542\/peds.12.4.447","article-title":"Dermatomyositis; report of 26 cases in children with a discussion of endocrine therapy in 13","volume":"12","author":"Wedgwood","year":"1953","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib11","first-page":"581","article-title":"Dermatomyositis: unusual features, complications, and treatment","volume":"74","author":"CHRISTIANSON","year":"1956","journal-title":"JAMA Dermatol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01.bor.0000434676.70268.66","article-title":"Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies","volume":"25","author":"Rothwell","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/BOR.0000000000000328","article-title":"New developments in genetics of myositis","volume":"28","author":"Rothwell","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar3327","article-title":"Recent advances in the immunogenetics of idiopathic inflammatory myopathy","volume":"13","author":"Chinoy","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/BOR.0b013e3283315a22","article-title":"An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond","volume":"21","author":"Chinoy","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jtauto.2019.100018_bib18","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/art.22205","article-title":"HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies","volume":"54","author":"O\u2019Hanlon","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.1780390910","article-title":"Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","article-title":"Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 Allelic Profiles and Motifs Define Clinicopathologic Groups in Caucasians","volume":"vol. 84","author":"O\u2019Hanlon","year":"2005","journal-title":"Med."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1","article-title":"Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci","volume":"42","author":"Rider","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1523-1747.2002.01869.x","article-title":"Associations of tumor necrosis factor \u03b1 and HLA polymorphisms with adult dermatomyositis: implications for a unique Pathogenesi1","volume":"119","author":"Werth","year":"2002","journal-title":"J.\u00a0Investig. Dermatol."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/rheumatology\/kem145","article-title":"Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies","volume":"46","author":"Chinoy","year":"2007","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/rheumatology\/ker379","article-title":"Genetic association study of NF-kappaB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy","volume":"51","author":"Chinoy","year":"2012","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/03009742.2012.669495","article-title":"The ACTN3 R577X polymorphism is associated with inflammatory myopathies in a Mexican population","volume":"41","author":"Sandoval-Garcia","year":"2012","journal-title":"Scand. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090019","article-title":"Association between a C8orf13-BLK polymorphism and polymyositis\/dermatomyositis in the Japanese population: an additive effect with STAT4 on disease susceptibility","volume":"9","author":"Sugiura","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib27","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1136\/annrheumdis-2011-200839","article-title":"Positive association between <em>STAT4<\/em> polymorphisms and polymyositis\/dermatomyositis in a Japanese population","volume":"71","author":"Sugiura","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110044","article-title":"Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis\/dermatomyositis in Chinese Han population","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12026-015-8738-x","article-title":"Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han","volume":"64","author":"Wang","year":"2016","journal-title":"Immunol. Res."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2006.068858","article-title":"Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/s10165-010-0311-9","article-title":"Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis\/polymyositis","volume":"20","author":"Gono","year":"2010","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jtauto.2019.100018_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2017.04.005","article-title":"Lessons learned from twins in autoimmune and chronic inflammatory diseases","volume":"83","author":"Generali","year":"2017","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2019.100018_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2016.06.009","article-title":"A\u00a0clinical update on the significance of the gut microbiota in systemic autoimmunity","volume":"74","author":"Rosser","year":"2016","journal-title":"J.\u00a0Autoimmun."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0889-857X(02)00026-1","article-title":"Animal models of myositis","volume":"28","author":"Nagaraju","year":"2002","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib35","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","article-title":"Environmental factors associated with disease flare in juvenile and adult dermatomyositis","volume":"56","author":"Mamyrova","year":"2017","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib36","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/art.11090","article-title":"Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease","volume":"48","author":"Okada","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib37","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib38","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/art.37985","article-title":"Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis","volume":"65","author":"Shah","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","article-title":"Opportunistic infections in polymyositis and dermatomyositis","volume":"53","author":"Marie","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"8540","key":"10.1016\/j.jtauto.2019.100018_bib40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(87)92271-9","article-title":"Dermatomyositis, polymyositis, and Coxsackie-B-virus infection","volume":"1","author":"Bowles","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00296-009-1231-x","article-title":"Dermatomyositis and HIV infection: case report and review of the literature","volume":"31","author":"Carroll","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib42","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","article-title":"Malignancy in dermatomyositis and polymyositis: analysis of 192 patients","volume":"35","author":"Fang","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3904\/kjim.2014.29.2.231","article-title":"Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma","volume":"29","author":"Yang","year":"2014","journal-title":"Korean J. Intern. Med."},{"issue":"14","key":"10.1016\/j.jtauto.2019.100018_bib44","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2169\/internalmedicine.56.7595","article-title":"Dermatomyositis induced by hepatitis B virus-related hepatocellular carcinoma: a case report and review of the literature","volume":"56","author":"Chou","year":"2017","journal-title":"Intern. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.semarthrit.2018.02.003","article-title":"The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis","volume":"48","author":"Schiffenbauer","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006604","article-title":"Beyond the MHC: a canine model of dermatomyositis shows a complex pattern of genetic risk involving novel loci","volume":"13","author":"Evans","year":"2017","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/BOR.0b013e328310e0ac","article-title":"Animal models in myositis","volume":"20","author":"Katsumata","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib48","first-page":"693","article-title":"Experimental models of inflammatory myopathies","volume":"2","author":"Rosenberg","year":"1993","journal-title":"Bailliere. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-4598(199701)20:1<72::AID-MUS10>3.0.CO;2-3","article-title":"Spontaneous myopathy in the SJL\/J mouse: pathology and strength loss","volume":"20","author":"Weller","year":"1997","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib50","first-page":"117","article-title":"Experimental autoimmune myositis in SJL\/J mice","volume":"68","author":"Rosenberg","year":"1987","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0140","article-title":"Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"4 Pt 2","key":"10.1016\/j.jtauto.2019.100018_bib52","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.lpm.2011.01.005","article-title":"Pathophysiology of inflammatory and autoimmune myopathies","volume":"40","author":"Dalakas","year":"2011","journal-title":"Presse Med."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1517\/17530051003713499","article-title":"Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies","volume":"4","author":"Schmidt","year":"2010","journal-title":"Expert Opin. Med. Diagn."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","article-title":"Immunobiology of muscle: advances in understanding an immunological microenvironment","volume":"26","author":"Wiendl","year":"2005","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib56","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.181.5.1863","article-title":"T\u00a0cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells","volume":"181","author":"Bender","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib57","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1073\/pnas.0236183100","article-title":"Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis","volume":"100","author":"Hofbauer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 5","key":"10.1016\/j.jtauto.2019.100018_bib58","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awh148","article-title":"Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity","volume":"127","author":"Schmidt","year":"2004","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib59","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"issue":"Pt 5","key":"10.1016\/j.jtauto.2019.100018_bib60","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/awg114","article-title":"Muscle fibres and cultured muscle cells express the B7.1\/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies","volume":"126","author":"Wiendl","year":"2003","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib61","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J.\u00a0Clin. Investig."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"Pt 7","key":"10.1016\/j.jtauto.2019.100018_bib65","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/brain\/aww122","article-title":"Microvascular alterations and the role of complement in dermatomyositis","volume":"139","author":"Lahoria","year":"2016","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib66","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T\u00a0cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells","volume":"183","author":"Fasth","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2019.100018_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13075-016-0974-5","article-title":"Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis","volume":"18","author":"Pandya","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib68","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","article-title":"Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies","volume":"29","author":"Hohlfeld","year":"1991","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib69","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/08916934.2017.1405942","article-title":"T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis","volume":"50","author":"Shimojima","year":"2017","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib70","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.4049\/jimmunol.167.7.4051","article-title":"Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis","volume":"167","author":"Nishio","year":"2001","journal-title":"J.\u00a0Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib71","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4049\/jimmunol.167.6.3521","article-title":"Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients","volume":"167","author":"Benveniste","year":"2001","journal-title":"J.\u00a0Immunol."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib72","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.152.5.2569","article-title":"Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies","volume":"152","author":"O\u2019Hanlon","year":"1994","journal-title":"J.\u00a0Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2019.100018_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","article-title":"FOXP3+ T regulatory cells in idiopathic inflammatory myopathies","volume":"225","author":"Waschbisch","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105353","article-title":"Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral blood","volume":"9","author":"Vercoulen","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jtauto.2019.100018_bib75","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib76","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10067-012-2075-4","article-title":"Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis","volume":"31","author":"Wang","year":"2012","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib77","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies","volume":"68","author":"Kry\u0161t\u016ffkov\u00e1","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib78","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","article-title":"The expression of BAFF in the muscles of patients with dermatomyositis","volume":"249","author":"Baek","year":"2012","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib79","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/bmm.13.124","article-title":"B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis","volume":"8","author":"Peng","year":"2014","journal-title":"Biomark. Med."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib80","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13075-014-0454-8","article-title":"Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52\/anti-Ro60 autoantibodies","volume":"16","author":"Kry\u0161t\u016ffkov\u00e1","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib81","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","article-title":"Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines","volume":"62","author":"Tournadre","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib82","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/NEN.0b013e31826bf7f3","article-title":"Toll-like receptors promote inflammation in idiopathic inflammatory myopathies","volume":"71","author":"Brunn","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib83","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.60.12.1137","article-title":"Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells","volume":"60","author":"Kikuchi","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib84","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A\u00a0local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J.\u00a0Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib85","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/eji.201343315","article-title":"The V(H) repertoire and clonal diversification of B cells in inflammatory myopathies","volume":"44","author":"McIntyre","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib86","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":"Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib87","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40265-014-0240-6","article-title":"Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment","volume":"74","author":"Hornung","year":"2014","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib88","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2230.2006.02150.x","article-title":"Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis","volume":"31","author":"Wenzel","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib89","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2133.2005.06786.x","article-title":"Evidence for a role of type I interferons in the pathogenesis of dermatomyositis","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.jtauto.2019.100018_bib90","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib91","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-\u03b1\/\u03b2\u2013mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","article-title":"Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells","volume":"50","author":"Page","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib93","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar4512","article-title":"Roles of mast cells in the pathogenesis of inflammatory myopathy","volume":"16","author":"Yokota","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib94","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cei.12319","article-title":"Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications","volume":"177","author":"Zhang","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mus.20088","article-title":"Monocyte\/macrophage differentiation in dermatomyositis and polymyositis","volume":"30","author":"Rostasy","year":"2004","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib96","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/ket360","article-title":"Role of activated macrophage and inflammatory cytokines in the development of calcinosis in juvenile dermatomyositis","volume":"53","author":"Shimizu","year":"2014","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib97","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3899\/jrheum.141307","article-title":"Elevated serum levels of soluble CD163 in polymyositis and dermatomyositis: associated with macrophage infiltration in muscle tissue","volume":"42","author":"Peng","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib98","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.4049\/jimmunol.169.12.7127","article-title":"Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis","volume":"169","author":"Ascherman","year":"2002","journal-title":"J.\u00a0Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib99","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatibility complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib100","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.4049\/jimmunol.164.12.6593","article-title":"Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production","volume":"164","author":"Sugiura","year":"2000","journal-title":"J.\u00a0Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib101","first-page":"154","article-title":"Expression of B7-homolog 1 in polymyositis","volume":"41","author":"Xiaoyu","year":"2011","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib102","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"issue":"Pt 6","key":"10.1016\/j.jtauto.2019.100018_bib103","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/brain\/120.6.929","article-title":"Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells","volume":"120","author":"Behrens","year":"1997","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib104","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","article-title":"MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis","volume":"55","author":"Schneider","year":"1996","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib105","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.164.10.5459","article-title":"The inhibition of apoptosis in myositis and in normal muscle cells","volume":"164","author":"Nagaraju","year":"2000","journal-title":"J.\u00a0Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2019.100018_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(99)00162-9","article-title":"Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies","volume":"106","author":"Li","year":"2000","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"21","key":"10.1016\/j.jtauto.2019.100018_bib107","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib108","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib109","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jbspin.2010.02.028","article-title":"Steroid-responsive dropped-head-syndrome due to polymyositis","volume":"77","author":"Finsterer","year":"2010","journal-title":"Jt. Bone Spine"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2009.04190.x","article-title":"Review article: the gastrointestinal complications of myositis","volume":"31","author":"Ebert","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib111","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.1780260804","article-title":"Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis","volume":"26","author":"de Merieux","year":"1983","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib112","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2008-1062267","article-title":"Inflammatory myopathies: evaluation and management","volume":"28","author":"Greenberg","year":"2008","journal-title":"Semin. Neurol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib113","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib114","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-011-0176-8","article-title":"Antisynthetase syndrome","volume":"13","author":"Katzap","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib116","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2008.169375","article-title":"Evaluation and treatment of inflammatory myopathies","volume":"80","author":"Amato","year":"2009","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib117","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib118","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.61.3.288","article-title":"Unicorns, dragons, polymyositis, and other mythological beasts","volume":"61","author":"Amato","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib119","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/03009742.2018.1488989","article-title":"A\u00a0case of Kennedy\u2019s disease misdiagnosed as polymyositis","volume":"48","author":"Shi","year":"2019","journal-title":"Scand. J. Rheumatol."},{"issue":"9125","key":"10.1016\/j.jtauto.2019.100018_bib120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(98)02326-5","article-title":"Macrophagic myofasciitis: an emerging entity. Groupe d\u2019Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l\u2019Association Francaise contre les Myopathies (AFM)","volume":"352","author":"Gherardi","year":"1998","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jtauto.2019.100018_bib121","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM199003293221301","article-title":"Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan","volume":"322","author":"Hertzman","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib122","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib123","doi-asserted-by":"crossref","first-page":"327","DOI":"10.7326\/0003-4819-98-3-327","article-title":"Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis","volume":"98","author":"Doyle","year":"1983","journal-title":"Ann. Intern. Med."},{"issue":"16","key":"10.1016\/j.jtauto.2019.100018_bib124","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"Dalakas","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jtauto.2019.100018_bib125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48\u201349","author":"Iaccarino","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib126","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11926-014-0465-0","article-title":"Amyopathic dermatomyositis: definitions, diagnosis, and management","volume":"16","author":"Bailey","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib127","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib129","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pcl.2005.01.004","article-title":"Inflammatory myopathies in children","volume":"52","author":"Compeyrot-Lacassagne","year":"2005","journal-title":"Pediatr. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib131","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib132","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rdc.2011.01.001","article-title":"Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features","volume":"37","author":"Khan","year":"2011","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"11","key":"10.1016\/j.jtauto.2019.100018_bib133","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A\u00a0novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib134","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity","volume":"87","author":"Bingham","year":"2008","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib136","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar4198","article-title":"Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?","volume":"15","author":"Tansley","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib137","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Danko","year":"2004","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib138","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib139","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2010.08.013","article-title":"Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review","volume":"148","author":"Gupta","year":"2011","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/BOR.0000000000000442","article-title":"Cardiovascular involvement in myositis","volume":"29","author":"Diederichsen","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"issue":"11","key":"10.1016\/j.jtauto.2019.100018_bib141","first-page":"686","article-title":"Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review","volume":"35","author":"Zhang","year":"2012","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib142","first-page":"461","article-title":"Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study","volume":"55","author":"Rai","year":"2016","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib143","first-page":"949","article-title":"Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography","volume":"262","author":"Rosenbohm","year":"2015","journal-title":"J.\u00a0Neurol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib144","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1536\/ihj.17-204","article-title":"Diagnostic approach to cardiac involvement in idiopathic inflammatory myopathies","volume":"59","author":"Chen","year":"2018","journal-title":"Int. Heart J."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2014-206812","article-title":"Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity","volume":"74","author":"Hughes","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib146","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semarthrit.2017.06.004","article-title":"Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement","volume":"47","author":"Albayda","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib147","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.ijcard.2012.09.109","article-title":"Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging","volume":"164","author":"Mavrogeni","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib148","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2005.038679","article-title":"Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib149","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s10067-007-0562-9","article-title":"Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study","volume":"26","author":"Ye","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib150","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.rmed.2007.02.017","article-title":"Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis","volume":"101","author":"Won Huh","year":"2007","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib151","first-page":"260","article-title":"High-resolution computed tomography characterization of interstitial lung diseases in polymyositis\/dermatomyositis","volume":"35","author":"Hayashi","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib152","first-page":"58","article-title":"Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis","volume":"32","author":"Fujisawa","year":"2005","journal-title":"J.\u00a0Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib153","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.131251","article-title":"Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases","volume":"41","author":"Saketkoo","year":"2014","journal-title":"J.\u00a0Rheumatol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib154","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098824","article-title":"Prognostic factors for myositis-associated interstitial lung disease","volume":"9","author":"Fujisawa","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib156","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"28","author":"Chen","year":"2009","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib157","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11926-012-0246-6","article-title":"Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment","volume":"14","author":"Mimori","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib158","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/rheumatology\/kes167","article-title":"Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort","volume":"51","author":"Chua","year":"2012","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib159","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s100670200104","article-title":"Idiopathic inflammatory myopathy with diffuse alveolar damage","volume":"21","author":"Lee","year":"2002","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.jtauto.2019.100018_bib160","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1002\/art.34657","article-title":"Brief report: association of HLA-DRB1*0101\/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population","volume":"64","author":"Gono","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib161","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the treatment of Jo1 antibody\u2013associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"J.\u00a0Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib162","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J.\u00a0Intern. Med."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib163","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"9250","key":"10.1016\/j.jtauto.2019.100018_bib164","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3349\/ymj.2006.47.4.519","article-title":"Malignancies in Korean patients with inflammatory myopathy","volume":"47","author":"Lee","year":"2006","journal-title":"Yonsei Med. J."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib166","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-4362.1998.00453.x","article-title":"Amyopathic dermatomyositis in Hong Kong -- association with nasopharyngeal carcinoma","volume":"37","author":"Fung","year":"1998","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib167","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib168","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2011.10.024","article-title":"Hematological malignancy associated with polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib169","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","article-title":"Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study","volume":"161","author":"Huang","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltim.)"},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib171","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","article-title":"Tumor antigen markers for the detection of solid cancers in inflammatory myopathies","volume":"14","author":"Amoura","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib172","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrc1255","article-title":"Paraneoplastic neurological degenerations: keys to tumour immunity","volume":"4","author":"Albert","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jtauto.2019.100018_bib173","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","article-title":"Cancer-associated myositis: clinical features and prognostic signs","volume":"1051","author":"Ponyi","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib174","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","article-title":"Cancer and myositis: new insights into an old association","volume":"18","author":"Levine","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","article-title":"Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study","volume":"87","author":"Hida","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib176","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib177","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"18","key":"10.1016\/j.jtauto.2019.100018_bib178","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2169\/internalmedicine.55.6706","article-title":"Gene expression profile of inflammatory myopathy with malignancy is similar to that of dermatomyositis rather than polymyositis","volume":"55","author":"Noda","year":"2016","journal-title":"Intern. Med."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.803","article-title":"Increased prevalence of celiac disease in idiopathic inflammatory myopathies","volume":"7","author":"Danielsson","year":"2017","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mus.20652","article-title":"Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy","volume":"35","author":"Selva-O\u2019Callaghan","year":"2007","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib181","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1742-1241.2004.00248.x","article-title":"Renal involvement in patients with polymyositis and dermatomyositis","volume":"59","author":"Yen","year":"2005","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib182","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MD.0000000000000015","article-title":"The spectrum of renal involvement in patients with inflammatory myopathies","volume":"93","author":"Couvrat-Desvergnes","year":"2014","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib183","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12016-015-8524-5","article-title":"Renal involvement in idiopathic inflammatory myopathies","volume":"52","author":"Cucchiari","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib184","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.1780210111","article-title":"Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations","volume":"21","author":"Clements","year":"1978","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib186","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/rheumatology\/kex262","article-title":"Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis","volume":"56","author":"Meneghel","year":"2017","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib187","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1525-1470.1996.tb00728.x","article-title":"Partial lipodystrophy associated with juvenile dermatomyositis: report of two cases","volume":"13","author":"Quecedo","year":"1996","journal-title":"Pediatr. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib188","first-page":"610","article-title":"Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities","volume":"28","author":"Huemer","year":"2001","journal-title":"J.\u00a0Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib189","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar3704","article-title":"Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine","volume":"14","author":"Schiopu","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib190","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/acr.21637","article-title":"Quality of life in adults with juvenile-onset dermatomyositis: a case-control study","volume":"64","author":"Tollisen","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib191","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kes232","article-title":"Aerobic fitness after JDM--a long-term follow-up study","volume":"52","author":"Mathiesen","year":"2013","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib192","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jtauto.2019.100018_bib193","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2014.01.025","article-title":"The diagnosis and classification of polymyositis","volume":"48\u201349","author":"Milisenda","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"issue":"11","key":"10.1016\/j.jtauto.2019.100018_bib194","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/40.11.1262","article-title":"Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies","volume":"40","author":"Miller","year":"2001","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib195","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0889-857X(02)00027-3","article-title":"Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies","volume":"28","author":"Rider","year":"2002","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib196","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jtauto.2019.100018_bib197","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fneur.2016.00064","article-title":"Idiopathic inflammatory myopathies: clinical approach and management","volume":"7","author":"Malik","year":"2016","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib198","first-page":"428","article-title":"Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis","volume":"31","author":"Yuan","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib199","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.1780371206","article-title":"Elevated serum levels of interleukin-1 receptor antagonist in polymyositis\/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response","volume":"37","author":"Gabay","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","article-title":"Clinical implications of autoantibody screening in patients with autoimmune myositis","volume":"39","author":"Ghirardello","year":"2006","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib201","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1759720X11415306","article-title":"Diagnosis and treatment of the idiopathic inflammatory myopathies","volume":"3","author":"Gazeley","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib202","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11926-013-0335-1","article-title":"Autoantibodies in polymyositis and dermatomyositis","volume":"15","author":"Ghirardello","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib203","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/rheumatology\/kem088","article-title":"The role of MRI in the assessment of polymyositis and dermatomyositis","volume":"46","author":"Tomasova Studynkova","year":"2007","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib204","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiographics.15.3.7624563","article-title":"The idiopathic inflammatory myopathies: spectrum of MR imaging findings","volume":"15","author":"Adams","year":"1995","journal-title":"RadioGraphics"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib205","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.2214\/AJR.08.1764","article-title":"MRI findings in inflammatory muscle diseases and their noninflammatory mimics","volume":"192","author":"Schulze","year":"2009","journal-title":"AJR Am. J. Roentgenol."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib206","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6","article-title":"Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy","volume":"43","author":"Kimball","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib207","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/rheumatology\/keh130","article-title":"Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis","volume":"43","author":"Maillard","year":"2004","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib208","first-page":"39","volume":"22","author":"Del Grande","year":"2011","journal-title":"Magnetic Resonance Imaging of Inflammatory Myopathies"},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib209","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","article-title":"An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)","volume":"45","author":"Brown","year":"2006","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11926-009-0042-0","article-title":"Ultrasound in the evaluation of the inflammatory myopathies","volume":"11","author":"Adler","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2009.04390.x","article-title":"Ultrasound in the inflammatory myopathies","volume":"1154","author":"Weber","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib213","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3899\/jrheum.120682","article-title":"Classification, diagnosis, and management of idiopathic inflammatory myopathies","volume":"40","author":"Lazarou","year":"2013","journal-title":"J.\u00a0Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib214","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbadis.2014.05.034","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","volume":"1852","author":"Luo","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2 Suppl 1","key":"10.1016\/j.jtauto.2019.100018_bib215","first-page":"S20","article-title":"Inclusion-body myositis: clinical, diagnostic, and pathologic aspects","volume":"66","author":"Engel","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib216","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coph.2010.03.001","article-title":"Inflammatory muscle diseases: a critical review on pathogenesis and therapies","volume":"10","author":"Dalakas","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib217","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1756285608097463","article-title":"Therapeutic advances and future prospects in immune-mediated inflammatory myopathies","volume":"1","author":"Dalakas","year":"2008","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib218","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11940-011-0119-8","article-title":"Immunotherapy of inflammatory myopathies: practical approach and future prospects","volume":"13","author":"Dalakas","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib219","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0967-5868(02)00271-0","article-title":"Inflammatory myopathies: how to treat the difficult cases","volume":"10","author":"Mastaglia","year":"2003","journal-title":"J.\u00a0Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib220","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","article-title":"Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial","volume":"20","author":"van de Vlekkert","year":"2010","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib221","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations","volume":"88","author":"Ernste","year":"2013","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib222","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0002-9343(83)90344-3","article-title":"Presentation, treatment, and prognosis of idiopathic inflammatory muscle disease in a rural hospital","volume":"75","author":"Hoffman","year":"1983","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib223","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"Am. J. Med."},{"issue":"5 Pt 1","key":"10.1016\/j.jtauto.2019.100018_bib224","first-page":"824","article-title":"Guidelines of care for dermatomyositis. American academy of dermatology","volume":"34","author":"Drake","year":"1996","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib226","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","article-title":"Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application","volume":"10","author":"Danieli","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"27","key":"10.1016\/j.jtauto.2019.100018_bib227","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A\u00a0controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib228","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0049-0172(90)90024-A","article-title":"Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment","volume":"20","author":"Ramirez","year":"1990","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib229","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.41.6.557","article-title":"Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases","volume":"41","author":"Hollingworth","year":"1982","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2019.100018_bib230","first-page":"S53","volume":"vol. 199","author":"Miller","year":"2002"},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib231","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine for polymyositis: long-term followup","volume":"24","author":"Bunch","year":"1981","journal-title":"Arthritis Rheum."},{"issue":"7566","key":"10.1016\/j.jtauto.2019.100018_bib232","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(68)90649-1","article-title":"Treatment of dermatomyositis with methotrexate","volume":"2","author":"Malaviya","year":"1968","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib233","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0190-9622(98)70562-6","article-title":"The value of methotrexate in dermatomyositis","volume":"38","author":"Zieglschmid-Adams","year":"1998","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib234","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/WCO.0b013e32834a9589","article-title":"Inflammatory myopathies: management of steroid resistance","volume":"24","author":"Dalakas","year":"2011","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib236","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ncpneuro0901","article-title":"B\u00a0cells as therapeutic targets in autoimmune neurological disorders","volume":"4","author":"Dalakas","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib237","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib238","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A\u00a0pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jtauto.2019.100018_bib239","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-221205","article-title":"Successful treatment using rituximab in a patient with refractory polymyositis complicated by scleroderma renal crisis","volume":"2017","author":"Innami","year":"2017","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/rheumatology\/kew396","article-title":"Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab","volume":"56","author":"Aggarwal","year":"2017","journal-title":"Rheumatology"},{"issue":"2\u20133","key":"10.1016\/j.jtauto.2019.100018_bib241","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12026-013-8408-9","article-title":"Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature","volume":"56","author":"Nalotto","year":"2013","journal-title":"Immunol. Res."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib242","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the anti-synthetase syndrome: a retrospective case series","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib243","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib244","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur. Neurol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib245","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.semarthrit.2017.10.010","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis","volume":"47","author":"Schiffenbauer","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib246","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A\u00a0high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib247","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A\u00a0randomized, pilot trial of etanercept in dermatomyositis","volume":"70","year":"2011","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib248","first-page":"2080","article-title":"Alemtuzumab (Campath-1H) for treatment of refractory polymyositis","volume":"35","author":"Thompson","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib249","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-011-9533-7","article-title":"Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis","volume":"31","author":"Reiff","year":"2011","journal-title":"J.\u00a0Clin. Immunol."},{"issue":"4 Pt 2","key":"10.1016\/j.jtauto.2019.100018_bib250","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.lpm.2010.12.012","article-title":"Therapy of polymyositis and dermatomyositis","volume":"40","author":"Marie","year":"2011","journal-title":"Presse Med."},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib251","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11926-012-0248-4","article-title":"Exercise in inflammatory myopathies, including inclusion body myositis","volume":"14","author":"Alexanderson","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib252","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","article-title":"Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training programme","volume":"37","author":"Wiesinger","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib253","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/CND.0b013e3181a23c86","article-title":"Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis","volume":"10","author":"Johnson","year":"2009","journal-title":"J.\u00a0Clin. Neuromuscul. Dis."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib254","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.22687","article-title":"Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: six-month, double-blind, randomized, placebo-controlled trial","volume":"57","author":"Chung","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota","volume":"146","author":"Bendewald","year":"2010","journal-title":"Arch. Dermatol."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib256","first-page":"303","article-title":"Incidence and prevalence of polymyositis and dermatomyositis in a","volume":"19","author":"Rosa","year":"2013","journal-title":"Health Management Organization in Buenos Aires"},{"issue":"19","key":"10.1016\/j.jtauto.2019.100018_bib257","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1157\/13113285","article-title":"[Polymyositis-dermatomyositis: incidence in Spain (1997-2004)]","volume":"129","author":"Vargas-Leguas","year":"2007","journal-title":"Med. Cl\u00ednica"},{"issue":"3","key":"10.1016\/j.jtauto.2019.100018_bib258","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/14397595.2013.844308","article-title":"Prevalence and incidence of polymyositis and dermatomyositis in Japan","volume":"24","author":"Ohta","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib259","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in korea: a nationwide population-based study","volume":"34","author":"Cho","year":"2019","journal-title":"J.\u00a0Korean Med. Sci."},{"issue":"7","key":"10.1016\/j.jtauto.2019.100018_bib260","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/ard.2008.093161","article-title":"Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences","volume":"68","author":"Bernatsky","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2019.100018_bib261","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-13-103","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis","volume":"13","author":"Smoyer-Tomic","year":"2012","journal-title":"BMC Muscoskelet. Disord."},{"issue":"5","key":"10.1016\/j.jtauto.2019.100018_bib262","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.23302","article-title":"Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan","volume":"45","author":"Furst","year":"2012","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib263","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study","volume":"165","author":"Kuo","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.jtauto.2019.100018_bib264","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC international workshop: inclusion body myositis, 2-4 december 2011, naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul. Disord."},{"issue":"8","key":"10.1016\/j.jtauto.2019.100018_bib265","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti\u2013Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib266","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","article-title":"Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional StudyDM-specific autoantibodies in patients with DM","volume":"147","author":"Hamaguchi","year":"2011","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib267","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"Am. J. Med."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib268","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5 and anti-TIF1-\u03b3 antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib269","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jpeds.2010.11.033","article-title":"Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis","volume":"158","author":"Kobayashi","year":"2011","journal-title":"J.\u00a0Pediatr."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib270","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41598-017-00240-6","article-title":"Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts","volume":"7","author":"Ge","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jtauto.2019.100018_bib271","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib272","first-page":"602","volume":"24","author":"Casciola-Rosen","year":"2012","journal-title":"Myositis autoantibodies"},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib273","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib274","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A\u00a0novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jtauto.2019.100018_bib275","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3899\/jrheum.160871","article-title":"Anti-hmgcr autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients","volume":"44","author":"Tansley","year":"2017","journal-title":"J.\u00a0Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2019.100018_bib276","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti\u2013signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jtauto.2019.100018_bib277","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib278","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.jtauto.2019.100018_bib279","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/rheumatology\/41.9.1040","article-title":"Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome","volume":"41","author":"Coppo","year":"2002","journal-title":"Rheumatology"},{"issue":"Suppl 3","key":"10.1016\/j.jtauto.2019.100018_bib280","first-page":"240","article-title":"THU0253ANTI-PM-SCL autoantibodies in polymyositis and dermatomyositis","volume":"71","author":"Plestilova","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib281","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.jtauto.2019.100018_bib282","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine (Baltim.)"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909019300188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909019300188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:34:32Z","timestamp":1762904072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909019300188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":282,"alternative-id":["S2589909019300188"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2019.100018","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymyositis and dermatomyositis \u2013 challenges in diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2019.100018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100018"}}